ENDPOINTS

UK’s drugmaker rebate plan draws scrutiny from industry

The UK government is planning to double the proportion of money drugmakers have to pay back on medicine sales to the National Health Service in a move that’s drawn backlash from industry. In the UK ...

Mar 14, 2025 - 18:50
 0
UK’s drugmaker rebate plan draws scrutiny from industry
The UK government is planning to double the proportion of money drugmakers have to pay back on medicine sales to the National Health Service in a move that’s drawn backlash from industry. In the UK ...
Read More

Tags:

Previous Article

Meet the Johnson CLPS Team Supporting NASA’s Lunar Exploration Goals

Next Article

HTC Vive are offering big discounts on select VR headsets this March

Related Posts

Emergent sells once troubled Baltimore site to Syngene

Emergent sells once troubled Baltimore site to Syngene

Mar 10, 2025  0

Mired in low expectations, Novo braces for upcoming CagriSema head-to-head trial

Mired in low expectations, Novo braces for upcoming Cag...

Mar 10, 2025  0

Can amylin drugs take over from GLP-1s in obesity? Partnerless Zealand thinks so

Can amylin drugs take over from GLP-1s in obesity? Part...

Feb 20, 2025  0